SCHEMBL7251410

SCHEMBL7251410

O=C(CCCc1c[nH]c2ccccc12)NC(Cc1ccccc1)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.66
▸ ALDH1A1 P00352 3/20 0.66
▸ L3MBTL1 Q9Y468 1/20 0.66
▸ KMT2A Q03164 7/20 0.61
▸ MEN1 O00255 5/20 0.61
▸ HCRTR1 O43613 1/20 0.61
▸ HPGD P15428 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ RECQL P46063 1/20 0.57
▸ MAPT P10636 6/20 0.54
▸ TDP1 Q9NUW8 3/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ LMNA P02545 1/20 0.52
▸ HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29869259 0.85 KMT2A (0.69) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL7250664 0.85 ALDH1A1 (0.73) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL7251382 0.82 BMP1 (0.56) KMT2AMEN1HCRTR1
SCHEMBL7849863 0.81 MAPT (0.61) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL7850854 0.81 MAPT (0.60) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL1231823 0.81 MEN1 (0.78) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL1233360 0.81 MEN1 (0.78) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL23417935 0.80 ALDH1A1 (1.00) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL6643764 0.80 MEN1 (0.76) KDM4EALDH1A1L3MBTL1KMT2AMEN1
SCHEMBL30712556 0.79 KDM4E (0.80) KDM4EALDH1A1L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030195212-A1 Novel melanocortin receptor agonists and antagonists MELACURE THERAPEUTICS AB (SE) 2003-10-16 — — US claimed
EP-1254114-A2 MELANOCORTIN RECEPTOR AGONISTS AND ANTAGONISTS Melacure Therapeutics AB (SE) 2002-11-06 — — EP claimed
WO-2001055106-A2 NOVEL MELANOCORTIN RECEPTOR AGONISTS AND ANTAGONISTS MELACURE THERAPEUTICS AB (SE) 2001-08-02 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195212-A1 Novel melanocortin receptor agonists and antagonists MC1R, MC5R, MC4R KDM4E 1977/4885ALDH1A1 2823/4885L3MBTL1 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback